JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
165.30 USD   -1.10%
08/12Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science
PR
08/12J&J to end sales of baby powder with talc globally next year
AQ
08/12There are two ways to see inflation data
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about JOHNSON & JOHNSON
08/12Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scruti..
PR
08/12J&J to end sales of baby powder with talc globally next year
AQ
08/12There are two ways to see inflation data
MS
08/12Johnson & Johnson To Discontinue Selling Talc-Based Baby Powder In 2023
MT
08/12MARKETSCREENER'S WORLD PRESS REVIEW : August 12, 2022
MS
08/12Johnson & Johnson's Janssen Secures License to WuXi's TESSA Technology
MT
08/12Johnson & Johnson to end global sales of talc-based baby powder in 2023
AQ
08/12Reuters-schedule/…
RE
08/11J&J to end sales of talc-based powder worldwide in 2023
AQ
08/11JOHNSON & JOHNSON : Consumer Health to Transition Global Baby Powder Portfolio to Cornstar..
PU
08/11US Stocks Close Mixed Thursday Following Surprise Producer Price Drop
MT
08/11US Stocks Close Mixed Thursday Following Surprise Producer Price Drop
MT
08/11Johnson & Johnson to Discontinue Talc-Based Baby Powder in 2023
DJ
08/11J&J COVID vaccine factory forced to trash even more doses
AQ
08/11Sanofi, GSK, Pfizer Shares Fall Amid Growing Concerns Around Zantac Litigation in US
MT
08/11MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 ..
MT
08/10UK coal mine decision delayed a second time
RE
08/09Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Co..
BU
08/08Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceutical..
BU
08/08Johnson & Johnson Announces Executive Changes
CI
08/05The Janssen Pharmaceutical Companies - European Commission Approves IMBRUVICA (ibrutini..
AQ
08/05FOCUS : 5 Stocks for Yield Lovers
MS
08/04South Africa Health Regulator Flags First Death Linked to Johnson & Johnson COVID-19 Ja..
MT
08/04The Janssen Pharmaceutical Companies of Johnson & Johnson Announces European Commission..
CI
08/03DA Davidson Cuts Price Target on Johnson & Johnson to $190 From $196, Reiterates Buy/Ad..
MT
08/03Johnson & Johnson's Q2 Headwinds Pull Back Optimism on FY2022 Performance, D.A. Davidso..
MT
08/02Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conferen..
BU
08/01Johnson & Johnson's Janssen Pharmaceutical Secures FDA Approval for Psoriatic Arthritis..
MT
08/01JOHNSON & JOHNSON : STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administrati..
PU
08/01J&J Gets FDA OK of Stelara for Pediatric Patients With Active Psoriatic Arthritis
DJ
07/29JOHNSON & JOHNSON MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
07/29Raphe Pharmaceutique Vendor Generic & OTC Self Care Contract Manufacturing Pharmaceutic..
AQ
07/27Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT and Lazertinib C..
AQ
07/26Plaintiffs Call J&J Talc Subsidiary Estimation Bid 'A Road to Nowhere'
DJ
07/26JOHNSON & JOHNSON : Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT..
PU
07/25Janssen Receives Positive CHMP Opinion for Novel Bispecific Antibody TECVAYLI (teclista..
AQ
07/25Greenback to hit US firms as Wall Street feels chill
AQ
07/22Johnson & Johnson Unit Says EMA Panel Backs Conditional Marketing Approval of Bone Marr..
MT
07/22Janssen Gets Positive CHMP Opinion for Tecvayli to Treat Blood Cancer
DJ
07/21UBS Adjusts Johnson & Johnson Price Target to $180 From $185, Maintains Neutral Rating
MT
07/20JOHNSON & JOHNSON : 2022 Second-Quarter Earnings Transcript
PU
07/20Wall Street Sees Cautiously Lower Open, Consolidating After Earnings Rally
MT
07/20Goldman Sachs Adjusts Price Target for Johnson & Johnson to $182 From $183, Maintains N..
MT
07/20Atlantic Equities Adjusts Price Target on Johnson & Johnson to $165 From $174, Maintain..
MT
07/20SVB Securities Adjusts Price Target on Johnson & Johnson to $194 From $200, Keeps Outpe..
MT
07/20US Futures in Holding Pattern, Consolidating After Earnings Rally
MT
07/20Raymond James Adjusts Price Target on Johnson & Johnson to $192 From $196, Keeps Outper..
MT
07/20Citigroup Adjusts Price Target on Johnson & Johnson to $201 From $205, Maintains Buy Ra..
MT
07/20SOCIAL BUZZ : Wallstreetbets Stocks Up Premarket; Netflix Poised to Rise After Reporting Q..
MT
07/20MORE TEARS : Johnson & Johnson cuts sales and profit forecasts
AQ
07/19US Stocks Notch Solid Gains Tuesday Amid Strong Corporate Earnings
MT
07/19ALEX GORSKY : JPMorgan adds former J&J chief Gorsky to board
RE
07/19SECTOR UPDATE : Health Care Stocks Rising on Tuesday
MT
07/19SECTOR UPDATE : Health Care Stocks Advance in Afternoon Trading
MT
07/19MIDDAY REPORT : US Equity Indices Advance While Treasuries Decline in Midday Trading
MT
07/19Johnson & Johnson Cuts 2022 Outlook on 'Unfavorable' Currency Impact Despite Improved S..
MT
07/19Wall Street Set for Gains After Slide on Apple News
MT
07/19SECTOR UPDATE : Health Care Stocks Climb Premarket Tuesday
MT
07/19Johnson & Johnson Seeks Acquisitions
CI
07/19TRANSCRIPT : Johnson & Johnson, Q2 2022 Earnings Call, Jul 19, 2022
CI
07/19WALL STREET STOCK EXCHANGE : To stick or not to stick with defensive stocks? That is the q..
MS
07/19Johnson & Johnson's Executive Vice President, General Counsel Michael Ullmann to Retire..
AQ
07/19Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022
AQ
07/19Johnson & Johnson Provides Sales Guidance for the Full Year of 2022
CI
07/19Stocks Set to Reverse Losses as US Futures Rise Pre-Bell; Asis
MT
07/19Strong Q2 at J&J, but outlook cut again due to dollar's rise
AQ
07/19Wall Street Leans Forward Pre-Bell; Futures Green, Europe Even, Asia Choppy
MT
07/19Genmab Says Net Sales of Darzalex Reach $2 Billion in Q2
MT
07/19JOHNSON & JOHNSON : 2Q22 Other Financial Disclosures (Excel)
PU
07/19JOHNSON & JOHNSON : What You Need to Know About Johnson & Johnson's 2022 Second-Quarter Ea..
PU
07/19JOHNSON & JOHNSON : 2022 Second-Quarter Press Release & Supplemental Schedules
PU
07/19JOHNSON & JOHNSON : 2022 Second-Quarter Infographic & Earnings Presentation
PU
07/19JOHNSON & JOHNSON : 2Q22 Other Financial Disclosures (PDF)
PU
07/19Johnson & Johnson Posts Higher Q2 Adjusted Earnings, Sales; Lowers Full-Year 2022 Outlo..
MT
07/19JOHNSON & JOHNSON : Q2 Earnings Snapshot
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOHNSON & JOHNSON